Windward Bio Closes $251.2 Million IPO Including Full Underwriters' Option Exercise
FROM THE WIRE · GLOBENEWSWIRE.COM
BASEL, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG ("Windward") (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, today announced the…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralNasdaq biotech listing with sizeable proceeds, relevant mainly for the new stock's trading.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Windward Bio closed an IPO of 11,838,234 shares at a public offering price of $17.00 per share.
- 02The underwriters' option for 1,544,117 additional shares was fully exercised.
- 03Gross proceeds from the IPO and concurrent private placement were approximately $251.2 million.
- 04The common shares have traded on the Nasdaq Global Select Market since November 13, 2026.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets